drugset / Trial / NCT00712894
Effects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial Infarction
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of three different vasodilators including diltiazem, verapamil and nitroglycerin for reversal of no-reflow/slow-flow during direct percutaneous coronary intervention for acute myocardial infarction.
Timeline
- Start
- 2006-12
- Primary completion
- 2009-04
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diltiazem | Small molecule | 400 ug | Other |
| Subject | Diltiazem | Small molecule | 2000 ug | Other |
| Comparator | Nitroglycerin | Unknown | 200 ug | Other |
| Comparator | Nitroglycerin | Unknown | 1000 ug | Other |
| Comparator | Verapamil | Other / unclassified | 200 ug | Other |
| Comparator | Verapamil | Other / unclassified | 1000 ug | Other |